EVENTS:   Building Resilient Portfolios in an Age of Disruption - Pavol Povala/Allocation Strategy - 19 Nov 25   NEW SERIES: Best Equity Long Ideas Conference Call 1 - Kevin Cassidy/Rosenblatt Securities & Andrew Freedman/Hedgeye & Jonathan Boyar/Boyar Research & Hamed Khorsand/BWS Financial & Pelham Smithers/Pelham Smithers Associates & Hemant Kotak/Kolytics & Benjamin Silverman/2Xideas - 20 Nov 25   UK Budget - How Did We Get Here, Why is UK Having Another Massive Tax Hike? - Mark Bathgate/Tweeddale Advisors - 21 Nov 25     ROADSHOWS: Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      
US, European and Asian SELL / SHORT Ideas

11 Nov 25 - 18 Dec 25

11 - 12 Nov San Francisco • 19 - 20 Nov Toronto • 02 Dec West Palm Beach • 03 Dec Miami • 04 Dec Boston • 09 Dec Dubai • 10 - 12 Dec London • 16 - 18 Dec New York

Vision Research
Robert Prather Robert Prather President & Managing Member Robert previously worked as a Research Associate – Rider Investments (2004 – 2006), Assistant Portfolio Manager – WestAM (2001 – 2004) and as a Senior Associate – PricewaterhouseCoopers (1998– 2000)
Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech

17 - 19 Nov 2025

London

Revelare Partners
Andrew Peters Andrew Peters Co-Founder & Managing Partner Andrew is a co-founder of Revelare Partners. He has more than 15 years of experience in sales, research development and sourcing investment ideas for institutional investors. Prior to Revelare, Andrew was the Managing Director of Sales at DeMatteo Research LLC from 2011 to 2023 working with the team to build and expand its client base. He began his career as an Institutional Salesperson at PCS Research Services in 2008. He received a B.A. in Financial Economics from the University of Rochester.
Fundamental US Healthcare Short Ideas

17 - 19 Nov 2025

London

Favus Institutional Research
Dr Elliot Favus Dr Elliot Favus CEO & Senior Analyst Dr. Favus is a pharmaceutical equity research specialist with buyside and sellside experience, including Senior Analyst roles at Och Ziff and Lazard. Earlier in his career, Dr. Favus spent 10 years working on human genetics projects at Harvard Medical School and the University of Chicago.
Senior Semiconductor Analyst

09 - 10 Dec 2025

London

Rosenblatt Securities
Kevin Cassidy Kevin Cassidy Senior Analyst, Semiconductors Kevin has 25+ years of industry experience, including at Texas Instruments and AMD, and 15+ years of experience covering the space. He is a top ranked stock picker in 3rd party ratings.